Your browser doesn't support javascript.
loading
Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis.
Pollak, Thomas A; Kempton, Matthew J; Iyegbe, Conrad; Vincent, Angela; Irani, Sarosh R; Coutinho, Ester; Menassa, David A; Jacobson, Leslie; de Haan, Lieuwe; Ruhrmann, Stephan; Sachs, Gabriele; Riecher-Rössler, Anita; Krebs, Marie-Odile; Amminger, Paul; Glenthøj, Birte; Barrantes-Vidal, Neus; van Os, Jim; Rutten, Bart P F; Bressan, Rodrigo A; van der Gaag, Mark; Yolken, Robert; Hotopf, Matthew; Valmaggia, Lucia; Stone, James; David, Anthony S; McGuire, Philip.
Afiliación
  • Pollak TA; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, King's College London, London, UK. thomas.pollak@kcl.ac.uk.
  • Kempton MJ; Precision Psychiatry Cluster, National Institute for Health Research Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK. thomas.pollak@kcl.ac.uk.
  • Iyegbe C; South London and Maudsley NHS Foundation Trust, London, UK. thomas.pollak@kcl.ac.uk.
  • Vincent A; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, King's College London, London, UK.
  • Irani SR; Precision Psychiatry Cluster, National Institute for Health Research Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.
  • Coutinho E; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, King's College London, London, UK.
  • Menassa DA; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
  • Jacobson L; Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
  • de Haan L; Division of Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, King's College London, London, UK.
  • Ruhrmann S; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
  • Sachs G; Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.
  • Riecher-Rössler A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
  • Krebs MO; Amsterdam UMC, University of Amsterdam, Psychiatry, Department Early Psychosis, Meibergdreef 9, Amsterdam, The Netherlands.
  • Amminger P; Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
  • Glenthøj B; Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria.
  • Barrantes-Vidal N; Medical Faculty, University of Basel, Basel, Switzerland.
  • van Os J; University of Paris, GHU-Paris, Sainte-Anne, C'JAAD, Hospitalo-Universitaire department SHU, Inserm U1266, Institut de Psychiatrie (CNRS 3557), Paris, France.
  • Rutten BPF; Centre for Youth Mental Health, University of Melbourne, 35 Poplar Road (Locked Bag 10), Parkville, VIC, 4853052, Australia.
  • Bressan RA; Orygen, The National Centre of Excellence in Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia.
  • van der Gaag M; Centre for Neuropsychiatric Schizophrenia Research (CNSR) & Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.
  • Yolken R; Departament de Psicologia Clínica I de la Salut (Universitat Autònoma de Barcelona), Fundació Sanitària Sant Pere Claver (Spain), Spanish Mental Health Research Network (CIBERSAM), Barcelona, Spain.
  • Hotopf M; Department of Psychiatry, UMC Utrecht Brain Centre, Utrecht, The Netherlands.
  • Valmaggia L; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Mental Health Research and Teaching Network, Maastricht University Medical Centre, P.O. Box 616, 6200 MD 464, Maastricht, The Netherlands.
  • Stone J; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Mental Health Research and Teaching Network, Maastricht University Medical Centre, P.O. Box 616, 6200 MD 464, Maastricht, The Netherlands.
  • David AS; PRISMA Clinic, Y-MIND-Institute for Prevention of Mental Disorders (PRISMA); LiNC-Lab Interdisciplinar Neurociências Clínicas, Escola Paulista de Medicina, Universidade Federal de São Paulo-UNIFESP, Sao Paulo, Brazil.
  • McGuire P; Stanley Neurovirology Division. Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Mol Psychiatry ; 26(6): 2590-2604, 2021 06.
Article en En | MEDLINE | ID: mdl-33077853

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Receptores de N-Metil-D-Aspartato Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Receptores de N-Metil-D-Aspartato Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido